Serum interleukin-8 as a serologic marker of activity in Behçet's disease
International Journal of Dermatology, cilt.44, sa.8, ss.657-660, 2005 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 44 Sayı: 8
- Basım Tarihi: 2005
- Doi Numarası: 10.1111/j.1365-4632.2004.02184.x
- Dergi Adı: International Journal of Dermatology
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.657-660
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: Immune dysregulation has been shown to be one of the major aspects of the yet unknown pathogenesis of Behçet's disease. Interleukin-8 (IL-8), a major chemokine with pivotal effects concerning leukocytes and endothelial cells, has been found to be elevated in patients with Behçet's disease. Aim: To evaluate the significance of elevated levels of IL-8 with respect to the activity of Behçet's disease. Methods: Sixty-seven consecutive patients with Behçet's disease (37 males, 30 females; 32.5 ± 9.3 years) were enrolled in our study. The number of active clinical manifestations at the time of serum sampling was recorded. The degree of association between disease activity and IL-8, C-reactive protein, and erythrocyte sedimentation rate was assessed. Results: Serum levels of IL-8 increased as the number of clinically involved organs increased (P < 0.05). C-reactive protein and the erythrocyte sedimentation rate showed no correlation with disease activity. Conclusions: Our study confirms that the IL-8 level is a more sensitive marker of disease activity than the erythrocyte sedimentation rate and C-reactive protein. It may be assumed that IL-8 plays an important role in the pathophysiology of Behçet's disease. © 2004 The International Society of Dermatology.